Skip Navigation LinksHome > December 2012 - Volume 40 - Issue 12 > Interferon-γ production by natural killer cells and cytomega...
Critical Care Medicine:
doi: 10.1097/CCM.0b013e318260c90e
Clinical Investigations

Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients*

Chiche, Laurent MD, PhD; Forel, Jean-Marie MD; Thomas, Guillemette MD; Farnarier, Catherine MD; Cognet, Céline PhD; Guervilly, Christophe MD; Zandotti, Christine MD; Vély, Frédéric PhD; Roch, Antoine MD, PhD; Vivier, Eric DVM, PhD; Papazian, Laurent MD, PhD

Supplemental Author Material
Collapse Box

Abstract

Objective: The mechanisms involved in cytomegalovirus reactivation in critically ill patients who were previously immunocompetent are still unknown. The current study was designed to evaluate the possible role of natural killer cells in the reactivation of cytomegalovirus in these patients.

Design: Prospective observational.

Setting: A medical intensive care unit of a university hospital.

Patients: Fifty-one subjects, including 15 patients who experienced cytomegalovirus reactivation (cases) during their intensive care unit stay and 15 patients who matched intensive care unit controls, selected from a cohort of consecutive nonimmunocompromised intensive care unit patients, as well as healthy controls.

Interventions: Tests included weekly systematic immunomonitoring and routine screening for cytomegalovirus infection until discharge from the intensive care unit or death. The immunophenotype and functions of natural killer cells were performed by flow cytometry, and serum levels of pro- and anti-inflammatory cytokines were determined by enzyme-linked immunosorbent assay.

Measurements and Main Results: The overall occurrence of cytomegalovirus reactivation in the cohort was 27%. No differences of natural killer cell effector functions were observed at admission between cases and controls. Instead, before cytomegalovirus reactivation, the ability of natural killer cells to secrete interferon-γ was significantly reduced in cases as compared with controls upon stimulation with antibody-coated target cells (p = .029) and with K562 cell stimulation (p = .029). No phenotypic or quantitative differences were observed between cases and controls. Cases exhibited higher levels of interleukin 10 (p = .031) and interleukin 15 (p = .021) than controls before cytomegalovirus reactivation.

Conclusions: Impaired natural killer cell function with reduced interferon-γ secretion precedes the occurrence of cytomegalovirus reactivation among previously immunocompetent critically ill patients.

© 2012 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.